mardi 22 août 2017
Johnson & Johnson ordered to pay $417M in trial over talc cancer risks
A California jury on Monday ordered Johnson & Johnson to pay $417 million US to a woman who claimed she developed ovarian cancer after using the company's talc-based products.
Related Posts:
Superbug resistant to all antibiotics killed Nevada woman, doctors say- Superbug resistant to all antibiotics killed Nevada woman, doctors say
- Dozens of people fall ill after eating oysters
- Opera singer Rhonda Head overcame brain tumours to reclaim her voice
- Opera singer Rhonda Head overcame brain tumours to reclaim her voice
Articles
0 comments:
Enregistrer un commentaire